Viral Enteric Infection

1

Review clinical trials related to Viral Enteric Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

To assess the efficacy and safety of use of drug product Reamberin® solution for infusion, 1.5 % (Scientific Technological Pharmaceutical Firm "POLYSAN") for pathogenetic therapy of viral enteric infection in children aged 1-6 years old in routine clinical practice. Trial population: children of both sexes at the age of 1-6 years old inclusive with viral enteric infection.

Participants needed: 300
Trial details
Age: 1-6Biological sex: AllType: ObservationalSponsor: POLYSAN Scientific & Technological Pharmaceutical CompanyUpdated: Jul 15, 2025Locations: 8
Eligibility criteria

Children of both sexes at the age of 1 to 6 years old inclusive; [+6]

Individual intolerance or known hypersensitivity to sodium meglumine, sodium suc... [+5]